REVIEW ARTICLE • Soyfood Consumption in Breast Cancer Survivors: Don't Overstate the Facts!
Mark Messina et al; ONCOLOGY Vol. 27 No. 5
Recently published research questions the need for the advised restriction against the use of soyfoods by women with a history of breast cancer.
• A Fitting Prescription for All: Whole Soyfoods as Part of a Varied Plant-Based Diet
REVIEW ARTICLE • The State of Prostate MRI in 2013: Into the Breach
Rajan T. Gupta et al; ONCOLOGY Vol. 27 No. 4
Our aims in this article are to describe the various imaging sequences that comprise the multiparametric MRI exam, as well as to review current literature on the strengths/weaknesses of these sequences.
• Multiparametric MRI: Standardizations Needed
REVIEW ARTICLE • Omics as Useful Tools in Clinical Practice: Are We There Yet?
Amelia B. Zelnak, Ruth M. O'Regan; ONCOLOGY Vol. 27 No. 3
Additional insight into the biology of ER-positive breast cancers, particularly the higher risk luminal B cancers, could aid in identifying potential targets and new, effective therapies.
• The Evolving Role of Multi-Gene Tests in Breast Cancer Management
CONFERENCE REPORT • T-DM1 Most Effective in Breast Cancer Patients With High HER2 Expression
Cancer Network brings exclusive coverage of the annual meeting of the American Association for Cancer Research (AACR), held April 6-10, 2013 at the Walter E. Washington Convention Center in Washington, DC. This meeting brings together the best and latest findings in all major areas of cancer research.
• Triple-Negative Breast Cancer—Utilizing Biomarkers for Better Therapeutic Strategies
REVIEW ARTICLE • Focal Therapy: A New Active Surveillance Tool?
Matvey Tsivian, Michael R. Abern, Thomas J. Polascik; ONCOLOGY Vol. 27 No. 1
In this review we focus on the recent evolution of the concept of focal therapy and the potential applications of this management approach within an array of options currently available for patients with localized prostate cancer.
• Focal Therapy of Prostate Cancer—The Challenge
"Come Home": A Medicare Innovation Center Project
Barbara L. McAneny, MD1
, December 18, 2012
The Come Home project will demonstrate that community oncology practices can aggressively manage the symptoms and complications of cancer and its treatment—and at the same time can save money by limiting the use of expensive sites of service like hospitals and emergency departments.
Combined-Modality Therapy for Early-Stage Hodgkin Lymphoma: Maintaining High Cure Rates While Minimizing Risks
Chris R. Kelsey, MD1, Anne W. Beaven, MD2, Louis F. Diehl, MD2, Leonard R. Prosnitz, MD1
, December 17, 2012
In Hodgkin lymphoma, as with many other malignancies, a combined-modality approach has proven successful. This tactic capitalizes on the relative advantages of both modalities, yet minimizes risk by avoiding intense exposure to either. This article will summarize the data supporting this approach in early-stage Hodgkin lymphoma.
• The Important Role of Secondary Treatment in Hodgkin Lymphoma
• Treatment for Favorable Localized Hodgkin Lymphoma
Adult Medulloblastoma, From Spongioblastoma Cerebelli to the Present Day: A Review of Treatment and the Integration of Molecular Markers
Nicole Shonka, MD1, Alba Brandes, MD2, John F. de Groot, MD3
, November 15, 2012
Here we present the history, staging system, and treatment of medulloblastoma, reviewing the prognostic value and clinical application of molecular subtyping while highlighting the differences between adult and pediatric disease.
• Medulloblastoma: Molecular Classifications and Prognostic Associations
• A Tale of Two Tumors: Pediatric and Adult Medulloblastoma
50 Shades of Pink—And Why It Helps to Know the Difference
Rebecca Bechhold, MD1
, May 17, 2013
Buy toxic chemicals and support breast cancer research! Not lying—just saw an ad on TV for weed killer and it had a pink ribbon logo on its packaging indicating, “A portion of every sale goes to support breast cancer research and awareness.” We have plenty of weed killer and a perfect lawn at our house, so I am no critic of the product. But have you noticed the pink ribbon logo on virtually every conceivable item or service?
I Can’t Talk to You With a Gun in My Face
Rebecca Bechhold, MD1
, May 3, 2013
How many times have you been killed for being the messenger with the bad news? You can often tell who is going to be angry when the CT scan shows recurrent disease. It is one of many things that are so stressful about being an oncologist. Let’s be honest; over the course of our career, we give a lot of bad news.
“This Is My Last Day on Earth”
Craig R. Hildreth, MD
, May 2, 2013
To my oncologist: You certainly were pleasant and compassionate. You also tended to minimize the gravity of the situation when my disease progressed. I know you’re not psychic, but when things are going badly, don’t be afraid to tell me you’re worried.
Conflicts of Interest in Medicine: What About Ties to Payers?
Frederic W. Grannis Jr., MD1
, April 5, 2013
Recently, the US government released new “Sunshine” standards requiring more rigorous disclosure of potential financial conflicts of interest in medicine. Such new standards are driven by revelations of misdeeds on the part of pharmaceutical and device manufacturers.
“How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
Rebecca Bechhold, MD1
, March 26, 2013
When you start seeing a patient for the first time who has been treated elsewhere and the previous oncologist has not followed standard protocol, how do you present this new way of doing things without alienating the patient or sounding critical of the previous doctor?
ONS: Infection Risk, Prevention, and Management
April 29, 2013
In this interview, Laura Zitella will be discussing challenges and considerations for management and prevention of infection in the oncology setting—in both patients with solid tumors and those with hematologic malignancies.
ONS: Nurse-Physician PACT Yields Sharp Decrease in Codes
April 29, 2013
A team of nurses and physicians from Huntsman Cancer Institute successfully implemented key changes in their Patient Acute Change Team that increased nurse involvement and reduced the number of codes by 90% in the outpatient setting since they were put in place 2 years ago.
ONS: Safe Handling of Chemotherapy
April 29, 2013
Oncology nurses from a community hospital in Cincinnati, Ohio implemented a two-pronged process for the safe handling of chemotherapy, improving nurses’ satisfaction and comfort levels regarding chemotherapy safety.
ONS: Genetics and Genomics Matters
April 25, 2013
This interview covers standards for healthcare provider competency in offering comprehensive genetic services, and highlights genetics/genomics resources for nurses.
Current Challenges in Metastatic Breast Cancer:
Patient Management and Treatment Strategies
Interactive Case Challenge Series
This series of case presentations (five individual cases) will provide oncologists and other healthcare professionals with strategies for evaluating evidence-based data on the latest treatments in metastatic breast cancer (MBC) and the application of that data into the development of individualized approaches to care, including overcoming resistance, in order to optimize management and outcomes for patients.
Go to Activity
CancerNetwork.com offers a variety of Continuing Medical Education (CME) programs based on ONCOLOGY review articles, supplements to ONCOLOGY, textbooks, roundtable discussions, e-learning programs, and webcasts. These interactive CME activities are offered to physicians and other healthcare professionals without charge by CME.
CME LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
See a list of more Oncology CME activities.
GO FOR THE GOLD
Diagnostic Champions’ Challenge on Cancer Network: Designed to test the knowledge and medical diagnostic skills of physicians and other healthcare professionals, Cancer Network's Diagnostic Champions' Challenge was created to educate and entertain. Test your skills by playing…
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access Judy Capko,
May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.